1例新冠肺炎合并腹股沟样皮肤病变和红细胞分布宽度增加

IF 1.1 Q4 ALLERGY
Satoko Minakawa MD, PhD, Yasushi Matsuzaki MD, PhD, Akari Terada MD, Shu Ogasawara PhD, Yuki Nishiya MD, PhD, Jin Irie MD, PhD, Yoshiya Ishizawa MD, PhD, Hiroyuki Hanada MD, PhD, Daisuke Sawamura MD, PhD
{"title":"1例新冠肺炎合并腹股沟样皮肤病变和红细胞分布宽度增加","authors":"Satoko Minakawa MD, PhD,&nbsp;Yasushi Matsuzaki MD, PhD,&nbsp;Akari Terada MD,&nbsp;Shu Ogasawara PhD,&nbsp;Yuki Nishiya MD, PhD,&nbsp;Jin Irie MD, PhD,&nbsp;Yoshiya Ishizawa MD, PhD,&nbsp;Hiroyuki Hanada MD, PhD,&nbsp;Daisuke Sawamura MD, PhD","doi":"10.1002/cia2.12272","DOIUrl":null,"url":null,"abstract":"<p>Coronavirus disease 2019 (COVID-19) is related to cutaneous manifestations.<span><sup>1</sup></span> Previous reports indicate that pernio-like lesions are cutaneous manifestations of COVID-19.<span><sup>1, 2</sup></span> We report a case of pernio-like lesions related to COVID-19.</p><p>A 74-year-old Japanese woman with diabetes and hypertension was diagnosed with COVID-19. She was living with her daughter's family, who had also been diagnosed with COVID-19. On illness day 6, she presented to our emergency department with malaise and worsening shortness of breath (saturation percentage of oxygen in the artery blood 74%). The chest radiograph detected her bilateral interstitial pneumonia, and the treatment of artificial respiration started. Favipiravir, dexamethasone, remdesivir, and empiric antibiotic therapy were administrated because of a positive blood culture (<i>Corynebacterium striatum</i>, <i>Klebsiella</i> species). She was given lactulose, subcutaneous low molecular heparin, and continuous intravenous heparin infusion for prevent COVID-19-related thrombosis. On illness day 13, her breathing became worse. Extracorporeal membrane oxygenation was started. On illness day 25, erythema was seen on her body. On illness day 27, erythema and maculopapular exanthema appeared on her trunk (Figure 1A), legs (Figure 1B), and hands (Figure 1C). A hemorrhagic rash appeared on her hands (Figure 1D). Pernio-like lesions were seen on her fingers (Figure 1E,F) and toes. Laboratory inspection clarified a normal white blood cell count (5860/mm), normal liver and kidney function, decreased hemoglobin (10.1 g/dl; normal range: 10.6–14.4 g/dl), hematocrit (31.5%; normal range: 32.1%–42.7%), platelet count (45,000/mm; normal range: 13,800–309,000/mm), increased C-reactive protein (CRP, 10.56 mg/dl; normal range &lt;0.3 mg/dl), lactate dehydrogenase (LD, 346 U/L; normal range: 119–229 U/L), fibrinogen-fibrin degradation product (FDP, 113.8 μg/ml; normal range &lt;5.0 μg/ml), dimerized plasmin fragment D (D-dimer, 55.5 μg/ml; normal range &lt;1.0 μg/ml), and red blood cell distribution width (RDW, 16.2%; normal range 11.5%–13.8%). Over the following days, gradual spontaneous improvement of skin lesions occurred. However, she became the cerebral infarction and died on illness day 44.</p><p>Previous studies found that 318 of 505 (63%) patients with dermatologic symptoms related to COVID-19 had pernio-like lesions.<span><sup>3</sup></span> Pernio-like lesions were sole symptoms in the 55% of patients.<span><sup>3</sup></span> Retiform purpura presented entirely in inpatients.<span><sup>1</sup></span> Mechanisms of COVID-19 coagulopathy have been proposed. In a hypercoagulable situation, the crosstalk between the inflammatory and hemostatic systems may advance for thrombosis in COVID-19.<span><sup>4</sup></span> Heparin resistance was observed in patients with COVID-19 infectious disease of the serious case.<span><sup>4</sup></span></p><p>Elevated RDW is associated with an increased risk for mortality from heart disease, pulmonary disease, sepsis, influenza, and cancer.<span><sup>5</sup></span> RDW related to the death rate in Cox proportional hazards models adjusted for age, D-dimer level, and common comorbidities such as diabetes and hypertension.<span><sup>5</sup></span> Patients whose RDW increased during hospitalization had higher mortality compared with those whose RDW did not change.<span><sup>5</sup></span></p><p>In our case, skin manifestations of sepsis with DIC or heparin-induced thrombocytopenia need to be considered. However, cutaneous manifestations, RDW, and levels of LD and D-dimer might be useful biomarkers to improve the efficiency of information input work related to symptoms of the determination of triage of patients with COVID-19.</p><p>The authors declare no conflicts of interest.</p><p>Approval of the research protocol: This study was approved by the Committee of Medical Ethics of Hirosaki University Graduate School of Medicine in Aomori, Japan. The patient was registrated to the trial was registered in the University Hospital Medical Information Network (UMIN) (Reservation No. UMIN000041301) by approved by the Committee of Medical Ethics of Hirosaki University Graduate School of Medicine in Aomori, Japan.</p><p>Informed Consent: Written informed consent was obtained from the patient's husband.</p><p>Registry and the Registration No. of the study/trial: 21,928.</p><p>Animal Studies: N/A.</p>","PeriodicalId":15543,"journal":{"name":"Journal of Cutaneous Immunology and Allergy","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2022-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cia2.12272","citationCount":"0","resultStr":"{\"title\":\"A case of COVID-19 with pernio-like skin lesions and increased red blood cell distribution width\",\"authors\":\"Satoko Minakawa MD, PhD,&nbsp;Yasushi Matsuzaki MD, PhD,&nbsp;Akari Terada MD,&nbsp;Shu Ogasawara PhD,&nbsp;Yuki Nishiya MD, PhD,&nbsp;Jin Irie MD, PhD,&nbsp;Yoshiya Ishizawa MD, PhD,&nbsp;Hiroyuki Hanada MD, PhD,&nbsp;Daisuke Sawamura MD, PhD\",\"doi\":\"10.1002/cia2.12272\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Coronavirus disease 2019 (COVID-19) is related to cutaneous manifestations.<span><sup>1</sup></span> Previous reports indicate that pernio-like lesions are cutaneous manifestations of COVID-19.<span><sup>1, 2</sup></span> We report a case of pernio-like lesions related to COVID-19.</p><p>A 74-year-old Japanese woman with diabetes and hypertension was diagnosed with COVID-19. She was living with her daughter's family, who had also been diagnosed with COVID-19. On illness day 6, she presented to our emergency department with malaise and worsening shortness of breath (saturation percentage of oxygen in the artery blood 74%). The chest radiograph detected her bilateral interstitial pneumonia, and the treatment of artificial respiration started. Favipiravir, dexamethasone, remdesivir, and empiric antibiotic therapy were administrated because of a positive blood culture (<i>Corynebacterium striatum</i>, <i>Klebsiella</i> species). She was given lactulose, subcutaneous low molecular heparin, and continuous intravenous heparin infusion for prevent COVID-19-related thrombosis. On illness day 13, her breathing became worse. Extracorporeal membrane oxygenation was started. On illness day 25, erythema was seen on her body. On illness day 27, erythema and maculopapular exanthema appeared on her trunk (Figure 1A), legs (Figure 1B), and hands (Figure 1C). A hemorrhagic rash appeared on her hands (Figure 1D). Pernio-like lesions were seen on her fingers (Figure 1E,F) and toes. Laboratory inspection clarified a normal white blood cell count (5860/mm), normal liver and kidney function, decreased hemoglobin (10.1 g/dl; normal range: 10.6–14.4 g/dl), hematocrit (31.5%; normal range: 32.1%–42.7%), platelet count (45,000/mm; normal range: 13,800–309,000/mm), increased C-reactive protein (CRP, 10.56 mg/dl; normal range &lt;0.3 mg/dl), lactate dehydrogenase (LD, 346 U/L; normal range: 119–229 U/L), fibrinogen-fibrin degradation product (FDP, 113.8 μg/ml; normal range &lt;5.0 μg/ml), dimerized plasmin fragment D (D-dimer, 55.5 μg/ml; normal range &lt;1.0 μg/ml), and red blood cell distribution width (RDW, 16.2%; normal range 11.5%–13.8%). Over the following days, gradual spontaneous improvement of skin lesions occurred. However, she became the cerebral infarction and died on illness day 44.</p><p>Previous studies found that 318 of 505 (63%) patients with dermatologic symptoms related to COVID-19 had pernio-like lesions.<span><sup>3</sup></span> Pernio-like lesions were sole symptoms in the 55% of patients.<span><sup>3</sup></span> Retiform purpura presented entirely in inpatients.<span><sup>1</sup></span> Mechanisms of COVID-19 coagulopathy have been proposed. In a hypercoagulable situation, the crosstalk between the inflammatory and hemostatic systems may advance for thrombosis in COVID-19.<span><sup>4</sup></span> Heparin resistance was observed in patients with COVID-19 infectious disease of the serious case.<span><sup>4</sup></span></p><p>Elevated RDW is associated with an increased risk for mortality from heart disease, pulmonary disease, sepsis, influenza, and cancer.<span><sup>5</sup></span> RDW related to the death rate in Cox proportional hazards models adjusted for age, D-dimer level, and common comorbidities such as diabetes and hypertension.<span><sup>5</sup></span> Patients whose RDW increased during hospitalization had higher mortality compared with those whose RDW did not change.<span><sup>5</sup></span></p><p>In our case, skin manifestations of sepsis with DIC or heparin-induced thrombocytopenia need to be considered. However, cutaneous manifestations, RDW, and levels of LD and D-dimer might be useful biomarkers to improve the efficiency of information input work related to symptoms of the determination of triage of patients with COVID-19.</p><p>The authors declare no conflicts of interest.</p><p>Approval of the research protocol: This study was approved by the Committee of Medical Ethics of Hirosaki University Graduate School of Medicine in Aomori, Japan. The patient was registrated to the trial was registered in the University Hospital Medical Information Network (UMIN) (Reservation No. UMIN000041301) by approved by the Committee of Medical Ethics of Hirosaki University Graduate School of Medicine in Aomori, Japan.</p><p>Informed Consent: Written informed consent was obtained from the patient's husband.</p><p>Registry and the Registration No. of the study/trial: 21,928.</p><p>Animal Studies: N/A.</p>\",\"PeriodicalId\":15543,\"journal\":{\"name\":\"Journal of Cutaneous Immunology and Allergy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.1000,\"publicationDate\":\"2022-08-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cia2.12272\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Cutaneous Immunology and Allergy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/cia2.12272\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ALLERGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cutaneous Immunology and Allergy","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cia2.12272","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

摘要

在活动性严重新冠肺炎-19感染患者中观察到肝素耐药性。红细胞分布(RDW)是反映细胞体积变化的全血细胞计数的一个组成部分,已被证明与多种疾病的发病率和死亡率升高有关。皮肤表现、RDW以及LD和D-二聚体水平可能是COVID-19患者分型的有用生物标志物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

A case of COVID-19 with pernio-like skin lesions and increased red blood cell distribution width

A case of COVID-19 with pernio-like skin lesions and increased red blood cell distribution width

Coronavirus disease 2019 (COVID-19) is related to cutaneous manifestations.1 Previous reports indicate that pernio-like lesions are cutaneous manifestations of COVID-19.1, 2 We report a case of pernio-like lesions related to COVID-19.

A 74-year-old Japanese woman with diabetes and hypertension was diagnosed with COVID-19. She was living with her daughter's family, who had also been diagnosed with COVID-19. On illness day 6, she presented to our emergency department with malaise and worsening shortness of breath (saturation percentage of oxygen in the artery blood 74%). The chest radiograph detected her bilateral interstitial pneumonia, and the treatment of artificial respiration started. Favipiravir, dexamethasone, remdesivir, and empiric antibiotic therapy were administrated because of a positive blood culture (Corynebacterium striatum, Klebsiella species). She was given lactulose, subcutaneous low molecular heparin, and continuous intravenous heparin infusion for prevent COVID-19-related thrombosis. On illness day 13, her breathing became worse. Extracorporeal membrane oxygenation was started. On illness day 25, erythema was seen on her body. On illness day 27, erythema and maculopapular exanthema appeared on her trunk (Figure 1A), legs (Figure 1B), and hands (Figure 1C). A hemorrhagic rash appeared on her hands (Figure 1D). Pernio-like lesions were seen on her fingers (Figure 1E,F) and toes. Laboratory inspection clarified a normal white blood cell count (5860/mm), normal liver and kidney function, decreased hemoglobin (10.1 g/dl; normal range: 10.6–14.4 g/dl), hematocrit (31.5%; normal range: 32.1%–42.7%), platelet count (45,000/mm; normal range: 13,800–309,000/mm), increased C-reactive protein (CRP, 10.56 mg/dl; normal range <0.3 mg/dl), lactate dehydrogenase (LD, 346 U/L; normal range: 119–229 U/L), fibrinogen-fibrin degradation product (FDP, 113.8 μg/ml; normal range <5.0 μg/ml), dimerized plasmin fragment D (D-dimer, 55.5 μg/ml; normal range <1.0 μg/ml), and red blood cell distribution width (RDW, 16.2%; normal range 11.5%–13.8%). Over the following days, gradual spontaneous improvement of skin lesions occurred. However, she became the cerebral infarction and died on illness day 44.

Previous studies found that 318 of 505 (63%) patients with dermatologic symptoms related to COVID-19 had pernio-like lesions.3 Pernio-like lesions were sole symptoms in the 55% of patients.3 Retiform purpura presented entirely in inpatients.1 Mechanisms of COVID-19 coagulopathy have been proposed. In a hypercoagulable situation, the crosstalk between the inflammatory and hemostatic systems may advance for thrombosis in COVID-19.4 Heparin resistance was observed in patients with COVID-19 infectious disease of the serious case.4

Elevated RDW is associated with an increased risk for mortality from heart disease, pulmonary disease, sepsis, influenza, and cancer.5 RDW related to the death rate in Cox proportional hazards models adjusted for age, D-dimer level, and common comorbidities such as diabetes and hypertension.5 Patients whose RDW increased during hospitalization had higher mortality compared with those whose RDW did not change.5

In our case, skin manifestations of sepsis with DIC or heparin-induced thrombocytopenia need to be considered. However, cutaneous manifestations, RDW, and levels of LD and D-dimer might be useful biomarkers to improve the efficiency of information input work related to symptoms of the determination of triage of patients with COVID-19.

The authors declare no conflicts of interest.

Approval of the research protocol: This study was approved by the Committee of Medical Ethics of Hirosaki University Graduate School of Medicine in Aomori, Japan. The patient was registrated to the trial was registered in the University Hospital Medical Information Network (UMIN) (Reservation No. UMIN000041301) by approved by the Committee of Medical Ethics of Hirosaki University Graduate School of Medicine in Aomori, Japan.

Informed Consent: Written informed consent was obtained from the patient's husband.

Registry and the Registration No. of the study/trial: 21,928.

Animal Studies: N/A.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.60
自引率
10.00%
发文量
69
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信